Product event summary: (b)(4) was not returned for evaluation.This complaint is associated with a clinical adverse event.Information provided by the indicated that the patient was hospitalized with a subtherapeutic international normalized ratio (inr) of 1.8 and a transient ischemic attack (tia) accompanied with schizophasia, which resolved twenty minutes later.A computed tomography (ct) scan of the head was negative.Based on the available information, there is no evidence to indicate that a device malfunction or performance issue caused or contributed to the reported event.Per the instructions for use, neurological dysfunction is a known potential complication associated with the implantation of a vad.Of note, the patient's reported medical history indicated the patient did not have a history of neurological dysfunction events.Possible clinical factors that may have contributed to this event include the patient¿s pre-existing history and related comorbidities, the progression of their underlying disease, issues related to the therapeutic use of anticoag ulant and antiplatelet medications and the patient's complex post-operative course.There are possible patient, pharmacological and procedural factors that may have contributed to this event.This regulatory report is being submitted as part of a retrospective review and remediation per (b)(4) due to an fda audit observation.Investigation of this event is completed and the file will be closed.If new information is received, the file will be re-opened and a supplemental will be submitted.If information is provided in the future, a supplemental report will be issued.
|